Established in 1981, the Drug Safety Research Unit (DSRU) is an independent unit which monitors, studies and communicates the safety and risk management of medicines.
Our aim is to achieve the highest possible scientific and ethical standards, by putting the interests of patients first and to work with integrity and fairness with all our partners.
Independent Scientific Excellence
Our activities are principally concerned with pharmacovigilance, that is, the detection of side-effects associated with the use of marketed drugs. The DSRU undertakes all forms of non-interventional research studies and evaluations of the safety of medicines and provides education and training in pharmacovigilance and related subjects. We have achieved both recognition and endorsement by the regulatory authorities, healthcare professionals and pharmaceutical industry worldwide.
Who We Are
The DSRU is an independent academic unit and registered charity (No. 327206), as well as an Associate Department of the School of Pharmacy and Biomedical Sciences, University of Portsmouth.
The work of the DSRU is overseen by a panel of Trustees, who are eminent scientists and clinicians with interests in drug safety. The DSRU is led by Director, Professor Saad Shakir, and comprises a team of epidemiologists, physicians, pharmacists and biomedical scientists, supported by expert IT and administrative staff.
DSRU Education and Training
DSRU Education and Training was established at the DSRU in 2000 with a small dedicated team who successfully manage a growing portfolio of popular training courses in pharmacovigilance, pharmacoepidemiology and related topics.
For more detail on the structure of the DSRU, please see our ‘Meet the Team‘ page.